Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis
暂无分享,去创建一个
Ravikumar Arvapalli | E. Blough | Nandini Manne | Steven N. Rogers | T. Shokuhfar | Mani Maheshwari | N. Nepal | S. Asano | Vellaisamy Selvaraj | K. Rice | Erin Fankenhanel | J. Ma
[1] Ravikumar Arvapalli,et al. Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles. , 2015, Biomaterials.
[2] Ravikumar Arvapalli,et al. Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticles , 2015, Data in brief.
[3] E. Jean-Baptiste. Cellular Mechanisms in Sepsis , 2007, Journal of intensive care medicine.
[4] M. Granado,et al. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression. , 2006, The Journal of endocrinology.
[5] G. Su,et al. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. , 2002, American journal of physiology. Gastrointestinal and liver physiology.